Dr. Michael E. Hull, MD
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Medical school
- Indiana University School of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 156
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Indiana University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
MO license 2007014770
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hca-Healthone DBA Swedish Medical Center Englewood, CO
- The Medical Center of Aurora & South Hospital Aurora, CO
- Sky Ridge Medical Center Lone Tree, CO
- HCA Healthone Rose Denver, CO
- HCA Healthone Presbyterian St. Lukes Denver, CO
Medical groups
- Healthone Irl PAthology Services LLC (23 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 156
- Services billed
- 583
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 702 | 274 |
| Pathology examination of tissue using a microscope, moderately high complexity | 209 | 94 |
| Special stained specimen slides to examine tissue, initial procedure | 199 | 107 |
| Microscopic genetic analysis of tumor, using computer-assisted technology | 192 | 25 |
| Special stained specimen slides to examine tissue, each additional procedure | 175 | 45 |
| Pathology examination of tissue using a microscope, moderately low complexity | 65 | 43 |
| Cell examination of specimen, selective cellular enhancement technique | 50 | 41 |
| Special stained specimen slides to examine tissue including interpretation and report | 42 | 17 |
| Pathology examination of specimen during surgery, first tissue block | 37 | 19 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 36 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 2 companies reported 3 payments worth $172 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $133 |
|---|---|
| Amgen Inc. | $38.82 |
| Food and Beverage | $172 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.